Recent News

• 09.04.2025 - STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
• 09.04.2025 - STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
• 09.04.2025 - STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements
• 09.04.2025 - STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements
• 09.03.2025 - STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules
• 09.03.2025 - STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules
• 09.02.2025 - STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions
• 09.02.2025 - STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions

Recent Filings

• 09.05.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.04.2025 - 8-K Current report
• 09.04.2025 - EX-99.1 EX-99.1
• 09.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.03.2025 - EX-99.1 EX-99.1
• 09.03.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 09.03.2025 - 8-K Current report
• 08.22.2025 - 8-K Current report
• 08.18.2025 - 8-K Current report
• 08.18.2025 - EX-99.1 EX-99.1